Adults with ADHD found to have reduced life expectancy

Adults who have been diagnosed with attention deficit hyperactivity disorder (ADHD) may be living shorter lives than they should, finds a world-first study led by UCL researchers.

Parkinson’s UK invests £2.1 million in Neumora Therapeutics for preclinical testing of new Parkinson’s drug

Parkinson’s UK is investing £2.1million to support Neumora Therapeutics to carry out preclinical testing of NMRA-NLRP3, a NLRP3 inhibitor with the potential to reduce inflammation

April 27, 2024

Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Personnel 26.10.2023 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

October 27, 2023

Judge in Astellas patent suit denies motion to bolster defendant’s case

A federal judge said drugmakers have “perverted” the intent of Congress when it passed the Hatch-Waxman Act as he declined to supplement his ruling against

June 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.